Home
Our Focus
Overview
Literature & Publications
Pipeline
Overview
Acute Ischemic Stroke
Preeclampsia
Clinical Trials
Overview
Acute Ischemic Stroke
Preeclampsia
ReMEDy2 Trial
Overview
About ReMEDy2
Stroke Disease
For Physicians
Trial Locations
About DiaMedica
Overview
Leadership
Careers
Contact
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Analyst Coverage
Financial Reports & SEC Filings
Governance
Resources
SEC Filings
Investors Relations
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Nasdaq Quote
Charts
Historical Data
Analyst Coverage
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Governance
Board of Directors
Board Committees
Governance Documents
Resources
Investor Contact
FAQ
Share Consolidation Instructions
Email Alerts
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Filing Type:
View All
10-K
10-K/A
10-Q
144
20FR12B
20FR12B/A
3
4
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
RW
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2014
2007
Date
Form
Description
PDF
XBRL
Pages
11/19/18
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-3.4
EX-4.13
EX-23.1
183
11/15/18
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
3
11/09/18
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-3.1
EX-3.2
EX-3.3
EX-3.5
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-4.6
EX-4.7
EX-4.8
EX-4.9
EX-4.10
EX-4.11
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.13
EX-10.14
EX-10.15
EX-21.1
EX-23.1
658
11/02/18
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
2
11/01/18
DRSLTR
Correspondence Related to Draft Registration Statement
2
11/01/18
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-3.1
EX-3.2
EX-3.3
EX-3.5
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-4.6
EX-4.7
EX-4.8
EX-4.9
EX-4.10
EX-4.11
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.13
EX-10.14
EX-10.15
EX-21.1
663
10/19/18
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-3.3
EX-3.6
EX-10.4
EX-10.12
EX-10.13
EX-10.14
EX-10.15
252
10/18/18
DRSLTR
Correspondence Related to Draft Registration Statement
5
10/15/18
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
3
09/17/18
DRSLTR
Correspondence Related to Draft Registration Statement
2
Previous
1…
25
26
27
28
29
30
31
32
33
34
Next
Email Alerts
Contacts
RSS News Feed